Therapeutic vaccines preferentially stimulate T cells against tumour-specific epitopes that
are created by DNA mutations or oncogenic viruses. In the setting of premalignant disease …

The approach of peptide-based anticancer vaccination has proven the ability to induce
cancer-specific immune responses in multiple studies for various cancer entities. However …

Adjuvants are used in many vaccines, but their mechanisms of action are not fully
understood. Studies from the past decade on adjuvant mechanisms are slowly revealing the …

Cytotoxic T lymphocytes (CTLs) specific for conserved viral antigens can respond to different
strains of virus, in contrast to antibodies, which are generally strain-specific. The generation …

This Feature Article discusses several classes of lipopeptide with important biomedical
applications as antimicrobial and antifungal agents, in immune therapies and in personal …

The induction of anti‐influenza cytotoxic T lymphocytes (CTL) in vivo by immunizing mice
with liposomes containing messenger RNA (mRNA) encoding the influenza virus …

This work describes the nature and strength of the immune response induced by various Toll-
like receptor ligands and their ability to act as vaccine adjuvants. It reviews the various …

Human cytomegalovirus (HCMV) is the leading cause of congenital viral infection and
mental retardation. HCMV infection, while causing asymptomatic infections in most …

First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
46147671&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

The cloning of the genes encoding cancer antigens has opened new possibilities for the
treatment of patients with cancer. In this study, immunodominant peptides from the gp100 …